Nairobi, KENYA – The Pharmacy and Poisons Board (PPB), in partnership with PATH, on Thursday 3rd July 2025 conducted a Good Manufacturing Practices (GMP) training for local pharmaceutical manufacturers as part of ongoing efforts to enhance regulatory standards in Kenya.

The training comes at a critical time as the country works toward attaining World Health Organisation (WHO) Maturity Level 3, a key milestone in regulatory capacity.

The session was officiated by Dr. Antony Toroitich, Director of Corporate Services, who represented the Chief Executive Officer, Dr. F. M. Siyoi. In his remarks, Dr. Toroitich underscored the need to address gaps identified during GMP inspections and to support the growth of a robust local pharmaceutical manufacturing sector.

He reaffirmed PPB’s commitment to safeguarding public health by ensuring that all health products and technologies (HPTs) manufactured locally meet the highest standards of safety, quality, and efficacy through sustained capacity building and strategic partnerships.

Ends…